Pseudopolymorphic Forms Of A Hiv Protease Inhibitor

Patent No. EP2314591 (titled "Pseudopolymorphic Forms Of A Hiv Protease Inhibitor") was filed by Janssen R&D Ireland on May 16, 2003. The application was issued on Feb 24, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
WITTKOPPMar 18, 2015HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
STRAWMANMar 17, 2015D YOUNG
ALFRED E TIEFENBACHERMar 6, 2015-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2314591

JANSSEN R&D IRELAND
Application Number
EP10180831A
Filing Date
May 16, 2003
Status
Patent Maintained As Amended
Jan 22, 2021
Publication Date
Feb 24, 2021